BiotechTube
Home/Neurizon Therapeutics/Dr Katie MacFarlane
DK

Dr Katie MacFarlane

Non‑Executive Director

Neurizon Therapeutics

Therapeutic Areas

Amyotrophic Lateral Sclerosis (ALS)Alzheimer's DiseaseParkinson's DiseaseHuntington's Disease

Neurizon Therapeutics Pipeline

DrugIndicationPhase
NUZ-001Amyotrophic Lateral Sclerosis (ALS)Phase 2/3 (Platform Trial)

Leadership Team at Neurizon Therapeutics

SD
Sergio Duchini
Executive Chairman
View full Neurizon Therapeutics profile